Prevalence of anti-lymphocyte IgM autoantibodies driving complement activation in COVID-19 patients

IntroductionCOVID-19 patients can develop autoantibodies against a variety of secreted and membrane proteins, including some expressed on lymphocytes. However, it is unclear what proportion of patients might develop anti-lymphocyte antibodies (ALAb) and what functional relevance they might have.Meth...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Ainhoa Pérez-Díez, Xiangdong Liu, Stephanie Calderon, Ashlynn Bennett, Andrea Lisco, Anela Kellog, Frances Galindo, Matthew J. Memoli, Joseph M. Rocco, Brian P. Epling, Elizabeth Laidlaw, Mike C. Sneller, Maura Manion, Glenn W. Wortmann, Rita Poon, Princy Kumar, Irini Sereti
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Frontiers Media S.A. 2024-04-01
Σειρά:	Frontiers in Immunology
Θέματα:	COVID-19 autoantibodies complement deposition anti-lymphocyte Ab lymphopenia convalescent COVID-19
Διαθέσιμο Online:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1352330/full
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!